A trehalose-based tetanus and diphtheria vaccine has passed a first human trial in 60 healthy adults, showing a safety profile and immune response comparable to approved vaccines. Larger trials and regulatory review are still needed, but the technology could reduce reliance on refrigeration in remote clinics.
(c) Ravi Roshan

Bakunang hindi kailangang laging malamig, pumasa sa unang trial

SOUTHAMPTON UNIVERSITY

Isang bakuna laban sa tetanus at diphtheria na gumagamit ng trehalose ang pumasa sa unang human trial sa 60 malulusog na adulto. Katulad ng aprubadong bakuna ang safety profile at immune response nito. Kailangan pa ng mas malalaking trial, pero maaari nitong bawasan ang pag-asa sa refrigeration sa malalayong klinika.

Read Full Story
← Back

Related Posts

Karamihan sa Nabasa

blank
Australia nagtakda ng human-made rule sa music charts
Instagram retirará videos grabados con gafas inteligentes Ray-Ban de Meta cuando muestren a creadores filmando en secreto y acosando a personas en espacios públicos, incluidos clips de bromas o abordajes. Meta todavía no detalló cómo aplicará la norma, pero ya ha eliminado dos cuentas grandes
Instagram hihigpitan ang pang-aabuso gamit ang smart glasses
blank
Sinuportahan ng UN ang mapang mas tumpak sa laki ng Africa
From August 11, companies in France may no longer make marketing calls unless consumers have given prior consent, replacing a no-call list that groups said was often ignored. Illegal calls can bring fines of up to €75,000 for individuals and €375,000 for companies, with exceptions for existing contracts.
France ipinagbawal ang sales calls nang walang pahintulot